Last reviewed · How we verify
Neurotrophic keratitis
Approved treatments
- Oxervate · Dompe farmaceutici s.p.a.
Oxervate works by binding to the high affinity nerve growth factor receptor to stimulate nerve growth and repair. - Oxervate · Dompe farmaceutici s.p.a.
Oxervate works by mimicking the natural nerve growth factor to stimulate nerve regeneration and promote healing in the cornea. - Oxervate · Dompé Farmaceutici S.p.A
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neurotrophic keratitis patent landscape — cliff calendar, originator estates, attackable patents
- Neurotrophic keratitis treatment landscape brief
- Neurotrophic keratitis treatment updates RSS
Frequently asked questions about Neurotrophic keratitis
What drugs treat Neurotrophic keratitis?
Tracked treatments include Oxervate.
What is the treatment for Neurotrophic keratitis?
Standard treatment for Neurotrophic keratitis includes Oxervate. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Neurotrophic keratitis patent cliff · Neurotrophic keratitis CI report
- Treatment: Oxervate · Dompe farmaceutici s.p.a.
- Treatment: Oxervate · Dompe farmaceutici s.p.a.
- Treatment: Oxervate · Dompé Farmaceutici S.p.A
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing